Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 |
filingDate |
2018-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a589654bed30c6370786cc5bdbd54edc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b52c8245a23848e8082a3b97faf5e66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72e416f26e9cce0a57049f533d4a789a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5aec86980e57269e47b21e6e265d25c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1fff95ff24c2ecf9ae1f3fb2a6566ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd6417d81bbb8063f1d923b14b34c4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c3de69e6141bbb13fe413b6d648534 |
publicationDate |
2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2018118972-A |
titleOfInvention |
Antibodies against paliperidone hapten and use thereof |
abstract |
An antibody against an antipsychotic drug paliperidone and use thereof. A method for producing an antibody or binding fragment thereof that binds to paliperidone, comprising: (i) selecting a host for antibody production; and (ii) a conjugate of paliperidone and an immunogenic carrier to the host. Inoculating a gate, wherein the host produces an antibody or binding fragment thereof that binds to paliperidone. [Selection figure] None |
priorityDate |
2012-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |